Korean Market
EXCH
BioNote
★

BioNote publishes corporate governance report: voluntary value-up plan established but board involvement limited, governance improvement tasks remain

 
OWNR
BioNote
★

Outside Director Park Chul-se Increases Stake by 1,950 Shares via Open Market Purchase… Limited Impact on Shareholder Value Due to Small Scale

 
PERI
BioNote
★★

Bionote Q1 2026: Net profit surge, 650K shares cancelled, ongoing litigation risk

 
EXCH
BioNote
★★★★

Strong 1Q 2026 Consolidated Results: Turnaround to Profit, Significant Revenue and OP Growth